A Newark-based biotherapeutics company has received a $1 million state grant to help it develop a new cancer treatment.
The money is part of an effort by the Delaware Division of Small Business to distribute $14 million from the federal State Small Business Credit Initiative by the end of the year.
“With this investment, we are literally going to save people’s lives, not just here in Delaware and in this region, but potentially around the world, with the latest mind-blowing incredible gene editing technologies,” said Gov. Matt Meyer, who toured CorriXR Therapeutics’ lab at the University of Delaware’s STAR Campus on Monday morning…